Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 109.50
Bid: 107.00
Ask: 112.00
Change: 4.50 (4.29%)
Spread: 5.00 (4.673%)
Open: 105.00
High: 109.50
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

20 Oct 2023 07:03

RNS Number : 7955Q
Intercede Group PLC
20 October 2023
 

20 October 2023

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

Appointment of Non-Executive Director

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce the appointment of Daniel O'Brien to the Board of Intercede as a Non-Executive Director with immediate effect.

 

Mr. O'Brien ('Dan') brings over 30 years' experience in financial roles across successful listed, PE backed and privately owned international organisations. Dan studied at the University of Cambridge prior to qualifying as a chartered accountant at Deloitte in 1991 where he spent 8 years working in Audit Assurance. He has held senior finance roles in a range of multinational companies including COLT Telecoms, Eidos Plc, Huveaux Plc as Group Finance Director, Shine Group as Chief Financial Officer and Tarsus Group as both Chief Financial Officer and Chief Operating Officer. At Tarsus, Dan was a lead executive overseeing the take private acquisition by Charterhouse and the subsequent sale of the business to Informa plc for approximately $1bn. Dan currently sits on the advisory board of several organisations including Cuil Bay Capital.

 

Royston Hoggarth, Chair of Intercede, commented:

 

"We are delighted to announce Dan's appointment as a Non-Executive Director. He brings a wealth of public and private company experience, and his strong technical, financial and commercial acumen will be of great value as we continue to execute our growth plans. Additionally, he will be appointed as Audit Chair with immediate effect, with Tina Whitley moving to Remuneration Chair and John Linwood as Nominations Chair."

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

Cavendish Capital Markets Limited

Tel. + 44 (0)20 7220 0500

Simon Hicks/Fergus Sullivan

Corporate Finance

Tim Redfern/Charlotte Sutcliffe

ECM

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and custom development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

For more information visit: www.intercede.com

 

INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES FOR COMPANIES ("AIM RULES")

Full name:

Daniel Philip O'Brien

Age:

56

Shareholding in the Company:

53,644

Current directorships and/or partnerships:

Historic directorships and/or partnerships (within the last five years):

 

 Cuil Bay Capital Ltd

Raccoon Media Group Limited

School-Home Support Service (UK)

AMB Tarsus Exhibitions SDN BHD

CapRegen BioSciences Limited

CapRegen Limited

CapRegen Magnum Limited

CapRegen Natural BioSciences Limited

CapRegen Nutraceuticals Limited

Fairs & Exhibitions (1992) Limited

Fairs And Exhibitions Limited

Metabolic Medical Institute, Inc.

PNO Exhibition Investment (Dubai) Limited

PT. Tarsus Indonesia SEA

Shenzhen Bo Ao Exhibition Co., Ltd

Smarter Shows (Tarsus) Limited

Tarsus America Limited

Tarsus Atlantic Limited

Tarsus Cardio, Inc.

Tarsus Cedar Limited

Tarsus China Limited

Tarsus Exhibition (Shanghai) Co., Ltd

Tarsus Exhibition (Shenzhen) Co., Ltd

Tarsus Exhibitions & Publishing Limited

Tarsus Exhibitions India Private Limited

Tarsus Group Limited

Tarsus Group Limited (Jersey Entity)

Tarsus Holdings Limited

Tarsus Investments Limited

Tarsus Leeward Limited

Tarsus Luzhniki Limited

Tarsus Martex

Tarsus Medical Limited

Tarsus New Media Limited

Tarsus Organex Limited

Tarsus Overseas Limited

Tarsus Publishing Limited

Tarsus Touchstone Limited

Tarsus UK Holdings Limited

Tarsus US Limited

Tarsus Windward Limited

Tiger Acquisitions (Jersey) Limited

Tiger Acquisitions Holding Limited

Tiger Acquisitions Intermediate Holding Limited

Tiger Acquisitions UK Limited

W.R.Kern Organisation Limited(The)

F&E (2008) Limited

Connect Biz, LLC

Tak Mexico Holdings, LLC

Tarsus Connect, LLC

Tarsus Map LLC

 

 

There is no further information to be disclosed in relation to the appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGLBDGGGDDGXG
Date   Source Headline
18th Jul 20177:00 amRNSDirector/PDMR Shareholding & TVR
13th Jun 20177:00 amRNSCollaborations with VMWare and Imagination
7th Jun 201712:06 pmRNSHolding(s) in Company
7th Jun 201712:01 pmRNSHolding(s) in Company
7th Jun 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSLaunch of MyIDaaS
25th May 20177:00 amRNSSchedule 2(g) Disclosure
23rd May 20177:00 amRNSAppointment of Chief Sales Officer
17th May 20177:00 amRNSNon-Executive Director Appointment
9th May 20177:00 amRNSContract Win
8th May 20173:45 pmRNSShare Incentive Plan
8th May 20177:00 amRNSIntercede announces Secure Login for WordPress
5th Apr 20177:00 amRNSTrading Update
31st Mar 20177:00 amRNSListing of Convertible Loan Notes
20th Mar 20177:00 amRNSAppointment of VP, US Gov't & Enterprise Sales
15th Mar 20173:03 pmRNSShare Incentive Plan
9th Mar 20177:00 amRNSAppointment of Adviser
3rd Mar 20177:00 amRNSTrading Update
27th Jan 201712:15 pmRNSResult of General Meeting
5th Jan 20177:00 amRNSReceipt of $3.0m Order
28th Dec 20167:00 amRNSDirectorate Change
28th Dec 20167:00 amRNSHalf-year Report
28th Dec 20167:00 amRNSProposed Fundraising
16th Sep 20162:15 pmRNSDirector/PDMR Shareholding
16th Sep 20167:00 amRNSTrading Update
14th Sep 20163:52 pmRNSResult of AGM
1st Aug 20167:00 amRNSIssue of Equity & Share Incentive Plan
7th Jun 20167:00 amRNSFinal Results
18th May 20167:00 amRNSShare Incentive Plan
7th Apr 20167:00 amRNSYear End Trading Update
21st Mar 20161:21 pmRNSShare Incentive Plan
1st Mar 20162:00 pmRNSMyID within Intel Authenticate
22nd Feb 20167:00 amRNSNew Android Security Platform
7th Jan 20163:28 pmRNSTransaction in Own Shares
3rd Nov 20157:00 amRNSHalf Yearly Report
7th Oct 20157:00 amRNSTrading Update
16th Sep 20154:40 pmRNSResult of AGM
2nd Sep 20152:53 pmRNSShare Award
30th Jul 20153:37 pmRNSShare Incentive Plan
6th Jul 20157:00 amRNSTrading Update
2nd Jun 20157:00 amRNSFinal Results
28th May 20157:00 amRNSIntercede & Good to deliver secure mobility
19th May 20157:00 amRNSNew Partner for Intercede's MyTAM Service
14th May 20157:00 amRNSShare Incentive Plan
13th May 20157:00 amRNSIntercede & Citrix to deliver secure mobility
21st Apr 20157:00 amRNSNew Partner for Intercede's MyTAM Service
2nd Apr 201512:00 pmRNSTrading Update
18th Mar 20157:00 amRNSShare Incentive Plan
16th Mar 20157:00 amRNSAppointment of Non-Executive Director
26th Feb 20157:01 amRNSNew Partner for Intercede's MyTAM Service

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.